Publicacións (76) Publicacións de MANUEL CAMPOS TOIMIL

2024

  1. Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction

    Biochemical Pharmacology, Vol. 230

  2. Effects of Sodium Nitroprusside on Lipopolysaccharide-Induced Inflammation and Disruption of Blood–Brain Barrier

    Cells, Vol. 13, Núm. 10

2023

  1. Correction: A Review of Population Pharmacokinetic Analyses of Linezolid (Clinical Pharmacokinetics, (2022), 61, 6, (789-817), 10.1007/s40262-022-01125-2)

    Clinical Pharmacokinetics

  2. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

    Biomedicine and Pharmacotherapy, Vol. 161

  3. Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints

    Cells, Vol. 12, Núm. 9

2022

  1. A Review of Population Pharmacokinetic Analyses of Linezolid

    Clinical Pharmacokinetics, Vol. 61, Núm. 6, pp. 789-817

  2. Development and Evaluation of Virola oleifera Formulation for Cutaneous Wound Healing

    Antioxidants, Vol. 11, Núm. 9

  3. Listado de medicamentos a evitar en atención primaria y su aplicación en pacientes polimedicados

    Galicia Clínica, Vol. 83, Núm. 1, pp. 6-11

  4. Nanomolar resveratrol reduces early alterations of pancreatitis and pancreatic cancer in pancreatic acinar cells

    Phytomedicine Plus, Vol. 2, Núm. 3

  5. Rhus coriaria L., a new candidate for controlling metabolic syndrome: a systematic review

    The Journal of pharmacy and pharmacology, Vol. 74, Núm. 1, pp. 1-12

  6. Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

    ChemMedChem, Vol. 17, Núm. 21

  7. The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders

    Frontiers in Psychiatry, Vol. 13

  8. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2021

  1. Crambescin C1 Acts as A Possible Substrate of iNOS and eNOS Increasing Nitric Oxide Production and Inducing In Vivo Hypotensive Effect

    Frontiers in Pharmacology, Vol. 12

  2. Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib

    Journal of Ethnopharmacology, Vol. 272

  3. Pharmacological Extracts and Molecules from Virola Species: Traditional Uses, Phytochemistry, and Biological Activity

    Molecules (Basel, Switzerland), Vol. 26, Núm. 4

  4. The emerging scenario of the gut–brain axis: The therapeutic actions of the new actor kefir against neurodegenerative diseases

    Antioxidants, Vol. 10, Núm. 11

  5. Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease: Limits and improvements

    British Journal of Clinical Pharmacology, Vol. 87, Núm. 5, pp. 2216-2227

  6. Therapeutic drug monitoring of voriconazole: Validation of a high performance liquid chromatography method and comparison with an ARK immunoassay

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 3, pp. 154-159

  7. cAMP Compartmentalization in Cerebrovascular Endothelial Cells: New Therapeutic Opportunities in Alzheimer's Disease

    Cells, Vol. 10, Núm. 8